BAX Baxter - changes reportable segments to two segments effective Q2 2026 - SEC filing - Pharmaceuticals segment now reported within infusi

BAX Baxter - changes reportable segments to two segments effective Q2 2026 - SEC filing - Pharmaceuticals segment now reported within infusion Therapies & platforms division - SEC filing